Soligenix Future Growth

Future criteria checks 2/6

Soligenix's earnings are forecast to decline at 12.1% per annum while its annual revenue is expected to grow at 44.2% per year. EPS is expected to grow by 44.4% per annum.

Key information

-12.1%

Earnings growth rate

44.4%

EPS growth rate

Biotechs earnings growth27.6%
Revenue growth rate44.2%
Future return on equityn/a
Analyst coverage

Low

Last updated16 Dec 2024

Recent future growth updates

Recent updates

Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma

Oct 05

U.S. FDA awards $2.6M grant for expanded study of Soligenix's HyBryte for skin cancer

Sep 12

Soligenix announces $2.6M FDA grant to further study blood cancer candidate

Sep 06

Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?

Sep 06
Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?

Soligenix GAAP EPS of -$0.06 beats by $0.03, revenue of $0.4M beats by $0.2M

Aug 12

Soligenix, SERB Pharma team up to develop therapy for ricin poisoning

Jul 25

Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?

Apr 22
Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?

Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?

Jan 03
Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?

Shareholders May Find It Hard To Justify Increasing Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation For Now

Sep 17
Shareholders May Find It Hard To Justify Increasing Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation For Now

Health Check: How Prudently Does Soligenix (NASDAQ:SNGX) Use Debt?

Aug 30
Health Check: How Prudently Does Soligenix (NASDAQ:SNGX) Use Debt?

Is Soligenix (NASDAQ:SNGX) Weighed On By Its Debt Load?

May 08
Is Soligenix (NASDAQ:SNGX) Weighed On By Its Debt Load?

What Type Of Returns Would Soligenix's(NASDAQ:SNGX) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 16
What Type Of Returns Would Soligenix's(NASDAQ:SNGX) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Earnings and Revenue Growth Forecasts

NasdaqCM:SNGX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261-9N/AN/A2
12/31/20251-9N/AN/A2
12/31/20240-7N/AN/A1
9/30/20240-7-8-8N/A
6/30/20240-7-8-8N/A
3/31/20241-7-8-8N/A
12/31/20231-6-9-9N/A
9/30/20231-8-10-10N/A
6/30/20231-10-11-11N/A
3/31/20231-10-12-12N/A
12/31/20221-14-13-13N/A
9/30/20221-15-12-12N/A
6/30/20221-15-12-12N/A
3/31/20221-15-11-11N/A
12/31/20211-13-12-12N/A
9/30/20211-13-13-13N/A
6/30/20211-12-13-13N/A
3/31/20212-12-13-13N/A
12/31/20202-18-11-11N/A
9/30/20203-15-10-10N/A
6/30/20203-16-9-9N/A
3/31/20204-15-8-8N/A
12/31/20195-9-8-8N/A
9/30/20195-10-8-8N/A
6/30/20195-9-6-6N/A
3/31/20195-8-8-8N/A
12/31/20185-9-7-7N/A
9/30/20186-8-7-7N/A
6/30/20186-7N/A-7N/A
3/31/20185-8N/A-6N/A
12/31/20175-7N/A-7N/A
9/30/20176-5N/A-6N/A
6/30/20177-6N/A-6N/A
3/31/20179-4N/A-6N/A
12/31/201610-3N/A-5N/A
9/30/201612-5N/A-5N/A
6/30/201613-1N/A-4N/A
3/31/201611-4N/A-5N/A
12/31/20159-8N/A-5N/A
9/30/20158-4N/A-4N/A
6/30/20157-11N/A-5N/A
3/31/20157-8N/A-4N/A
12/31/20147-7N/A-2N/A
9/30/20146-8N/A-3N/A
6/30/20144-10N/A-4N/A
3/31/20143-12N/A-4N/A
12/31/20133-10N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SNGX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SNGX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SNGX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SNGX's revenue (44.2% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: SNGX's revenue (44.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SNGX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:57
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Soligenix, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LeBoyerAegis Capital Corporation
James MolloyAlliance Global Partners
Jonathan AschoffBrean Capital